The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes

NCT01595789 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

41

Enrollment

INDIV

Sponsor class

Conditions

Coronary Artery Disease
Diabetes Mellitus, Type 2

Interventions

DRUG: Liraglutide
DRUG: Placebo

Sponsor

Haugaard, Steen Bendix, M.D., DMSc